Evaluating Evidence in Lifestyle Medicine: A Practical Guide for Health Professionals in Viet Nam

RESEARCH & IMPLEMENTATIONLIFESTYLE MEDICINE IN VIET NAM

9/24/202625 min read

Evaluating Evidence in Lifestyle Medicine: A Practical Guide for Health Professionals in Viet Nam

Last reviewed: November 7, 2026

A published study can make a lifestyle intervention appear convincing. It may report that a particular dietary pattern reduces disease risk, an exercise program improves metabolic health, or a behavioral intervention helps people maintain healthier habits.

But the existence of a published study does not automatically mean that its findings are reliable, clinically meaningful or applicable to the person receiving care.

Two studies investigating the same intervention may report different results. A randomized trial may demonstrate improvement in a laboratory measurement without establishing a benefit for long-term health. A large observational study may identify an association that is partly explained by differences between the people being compared.

Even a well-conducted study may have limited relevance to patients in Viet Nam if the intervention requires resources, professional support or living conditions that differ substantially from those available locally.

This is why evidence-based Lifestyle Medicine requires more than finding research that supports a recommendation.

It requires healthcare professionals to understand what was studied, how the research was conducted, how much confidence can be placed in the findings and whether those findings should influence a particular clinical or public health decision.

The distinction is especially important in Lifestyle Medicine because its evidence base includes many different types of research, from randomized clinical trials and long-term cohort studies to behavioral science, implementation research and population health investigations.

No single study design can answer every question.

For healthcare professionals in Viet Nam, the objective should be to use the most appropriate evidence for the question, recognize uncertainty and translate reliable findings into safe, person-centered and professionally responsible care.

Evidence-Based Lifestyle Medicine Begins With the Right Question

Before evaluating a study, it helps to identify exactly what decision the evidence is intended to support.

A common framework involves defining the population, intervention, comparator and outcomes, often described as PICO. The relevant timeframe should also be considered.

For example, asking whether regular physical activity is associated with lower cardiovascular risk is different from asking whether a particular exercise program reduces blood pressure in adults with hypertension.

A third question might be whether a brief consultation delivered by a primary care physician increases the patient's physical activity over the following six months.

These questions are related, but they are not interchangeable.

The first concerns the association between a behavior and a health outcome. The second examines the effect of a defined intervention. The third evaluates whether a particular healthcare delivery approach can change behavior.

Each question may require different evidence.

The distinction is important because clinical recommendations often involve more than one step.

Evidence may establish that a healthy dietary pattern is associated with better health. A separate body of research may be needed to determine whether a specific counseling program can help patients adopt that pattern. Further evidence may be required to assess whether the program improves clinical outcomes and whether its benefits are sustained.

For Lifestyle Medicine, a scientifically sound recommendation should therefore be clear about the intervention, intended population, expected outcome and strength of the supporting evidence.

Without that clarity, it becomes easy to move from a reasonable observation to a claim that the research does not actually establish.

What Different Study Designs Can Tell Us

A useful starting point is understanding the strengths and limitations of the main research designs used in Lifestyle Medicine.

Randomized controlled trials are particularly valuable when researchers want to estimate the effects of a defined intervention.

Randomly assigning participants to intervention and comparison groups helps reduce differences in known and unknown factors that might otherwise influence the results.

For example, a randomized trial may compare a structured dietary intervention with usual care among adults with type 2 diabetes.

When properly designed and conducted, the trial can provide important evidence about the intervention's effects on outcomes such as glucose control, body weight or medication requirements.

However, randomization does not automatically guarantee reliable results. Problems with participant selection, implementation, missing data, outcome measurement or analysis may still undermine confidence.

Prospective cohort studies follow participants over time and examine relationships between exposures and subsequent outcomes.

They are especially useful for investigating long-term dietary patterns, physical activity, tobacco exposure, sleep and other behaviors that develop over years or decades.

Such studies can identify important associations and provide evidence relevant to prevention and population health.

However, people who follow different lifestyle patterns may also differ in socioeconomic circumstances, underlying health, medication use, healthcare access and other factors that influence outcomes.

These differences can make causal interpretation difficult.

Case-control studies can be useful when investigating relatively uncommon diseases or outcomes. Researchers compare people who have experienced an outcome with those who have not and examine relevant previous exposures.

These studies can provide valuable information, but selection of comparison groups, accurate measurement of past exposures and possible recall bias require careful attention.

Cross-sectional studies provide information about characteristics or health conditions measured at a particular time.

They can be useful for estimating the prevalence of behaviors, symptoms or risk factors in a population.

However, because exposure and outcome are often measured simultaneously, they generally cannot establish which came first.

An association identified in a cross-sectional survey should not automatically be presented as evidence that one factor caused another.

Qualitative research can help explain patient experiences, cultural considerations, barriers to behavior change and the acceptability of interventions.

It does not usually estimate treatment effectiveness in the same way as a randomized trial, but it can provide essential information about why an intervention may or may not be feasible.

Implementation research examines how interventions are adopted, delivered, maintained and evaluated in real healthcare settings.

For Viet Nam, this evidence can be particularly important when considering staffing, consultation time, costs, referral pathways and the practical requirements for integrating Lifestyle Medicine into routine care.

Mechanistic and laboratory studies can help explain biological processes and generate hypotheses. However, biological plausibility alone does not establish that an intervention improves meaningful clinical outcomes.

The appropriate study design therefore depends on the question being asked.

How to Read a Randomized Controlled Trial

Randomized trials are often regarded as the strongest design for evaluating clinical interventions, but their quality still requires assessment.

The first question concerns how participants were allocated.

Was the randomization process appropriate? Was allocation concealed until participants were enrolled? Were the groups reasonably comparable at baseline?

Proper allocation reduces the possibility that researchers, clinicians or participants could influence which group a person enters.

The next question concerns the intervention itself.

Was it clearly described? Did participants receive the intended intervention? Was the comparison group appropriate? Were other treatments or forms of support similar between groups?

These details are particularly relevant in Lifestyle Medicine.

A dietary intervention may involve nutrition counseling, group sessions, regular telephone support, meal planning and frequent monitoring.

If the comparison group receives only a leaflet, the trial is evaluating an entire support program rather than the effect of one dietary recommendation in isolation.

The amount of professional contact may also influence outcomes.

A clinician reading the study should therefore ask whether the intervention could be reproduced in the intended healthcare setting.

Blinding presents another challenge.

Participants usually know whether they are receiving an exercise program, changing their diet or attending behavioral counseling.

The absence of blinding does not automatically invalidate a lifestyle trial, but it may influence expectations, behavior, co-interventions and the assessment of subjective outcomes.

Objective measurements can reduce some concerns, although measurement procedures still need appropriate quality control.

Loss to follow-up is another important issue.

If participants who experience difficulties are more likely to withdraw, the remaining group may appear more successful than the entire population originally assigned to the intervention.

The analysis should also be examined.

An intention-to-treat approach generally preserves the comparison created by randomization by analyzing participants according to their assigned groups, although the handling of missing outcomes and other methodological details still matters.

An analysis restricted only to participants who completed the program may provide useful information about adherence, but it can also introduce bias if those participants differ systematically from those who discontinued.

Finally, the outcomes should be assessed.

Did the study measure something important to patients, such as symptoms, function, quality of life, hospitalizations or clinically significant events? Or did it measure only an intermediate outcome?

A well-designed trial may establish that an intervention improves blood pressure over 12 weeks. That does not necessarily establish that the same intervention reduces cardiovascular mortality over ten years.

The claim should remain proportionate to the evidence.

Observational Research: Valuable Evidence With Important Limitations

Lifestyle Medicine relies heavily on observational research because many behaviors and exposures cannot be randomized over long periods.

It would be unethical to assign people to smoke cigarettes for decades to determine whether smoking causes cancer.

Similarly, long-term random assignment to particular dietary patterns or physical activity levels may be impractical, difficult to sustain or unable to capture the full duration of exposure relevant to chronic disease.

Observational evidence is therefore essential.

However, interpreting it requires attention to confounding and bias.

Consider a study reporting that people who exercise regularly have lower mortality than those who are inactive.

The association may reflect a genuine health benefit of physical activity.

But the groups may also differ in smoking, income, education, existing illness, access to medical care or other characteristics.

People with serious illness may become less active because they are already unwell. In that situation, part of the observed association may reflect reverse causation rather than an effect of physical inactivity alone.

Statistical adjustment can reduce measured confounding, but it does not guarantee that all relevant differences have been removed.

Researchers may use methods such as propensity-score approaches, carefully defined comparison groups or designs that attempt to emulate a hypothetical randomized trial.

These methods can strengthen observational research when appropriately applied.

However, their reliability depends on the quality of the underlying data, the assumptions made and the ability to address important sources of bias.

The most appropriate conclusion is not that observational studies are inherently unreliable.

It is that observational associations should be interpreted according to their design, limitations and the wider body of evidence before causal claims are made.

Selection Bias: Who Entered the Study, and Who Was Left Out?

Selection bias deserves particular attention because it can affect both the trustworthiness and practical relevance of Lifestyle Medicine research.

A study may recruit participants from a specialist clinic, a university, a workplace wellness program or an online health community.

These participants may differ substantially from the wider population.

For example, people who voluntarily enroll in an intensive lifestyle program may be more motivated, have higher health literacy or possess greater financial flexibility than those who do not participate.

If a study reports high adherence and favorable outcomes among these volunteers, the results may not necessarily be reproduced in a typical primary care clinic.

However, it is important to distinguish limited representativeness from internal selection bias.

A randomized trial involving highly motivated volunteers may still provide a valid estimate of the intervention effect among those participants if randomization and other methods are sound.

The main concern may be whether the findings apply to a broader population.

By contrast, bias affecting the estimated intervention effect can occur when selection into the study or analysis depends inappropriately on characteristics related to both the intervention and the outcome.

For example, an observational study may include only people who successfully completed a lifestyle program and compare them with people who did not participate.

Those who completed the program may already differ in ways that predict better health outcomes.

The observed difference cannot automatically be attributed to the intervention.

Missing follow-up data can create further problems when participants who deteriorate, experience adverse effects or struggle with adherence are less likely to be included in the final analysis.

Selection issues may also arise in digital health research.

Participants who own smartphones, use wearable devices and complete regular electronic assessments may differ from people with limited digital access or lower health literacy.

For Vietnamese healthcare organizations, these distinctions matter because interventions evaluated among selected urban or highly educated populations may require substantial adaptation before being offered more broadly.

The question is not simply how many participants were included.

It is who they were, how they were selected, who remained in the study and whether those differences could change the interpretation of the findings.

Indirect Evidence: When a Study Does Not Quite Answer the Clinical Question

One of the most useful concepts in evidence appraisal is indirectness.

In the Grading of Recommendations Assessment, Development and Evaluation framework, commonly known as GRADE, indirectness concerns how closely the available evidence matches the actual question being considered.

The mismatch may involve the population, intervention, comparator or outcomes.

For example, a trial conducted among relatively healthy middle-aged adults may provide useful information about an exercise program.

However, its results may not directly answer whether the same program is safe and effective for frail older adults with several chronic conditions.

The intervention may also differ.

A study may evaluate a comprehensive lifestyle program involving individualized counseling, frequent follow-up and multidisciplinary care.

A hospital may be considering a simpler model consisting of one consultation and written educational materials.

Although both approaches involve lifestyle counseling, they are not equivalent interventions.

The comparator matters as well.

An intervention shown to be better than no structured support may not necessarily be better than a well-established local care pathway that already provides nutrition counseling, medication management and regular follow-up.

Outcomes can also create indirectness.

A trial demonstrating improved body weight or glycated hemoglobin does not directly establish reduced cardiovascular events, hospitalization or mortality.

These intermediate outcomes may be clinically important, but their relationship with longer-term outcomes must be considered rather than assumed.

Time is another consideration.

An intervention evaluated over three months may not provide sufficient evidence about adherence, safety or effectiveness over several years.

The GRADE framework treats indirectness as one of the factors that may reduce confidence in a body of evidence.

This does not mean indirect evidence has no value.

It means the gap between the research and the decision needs to be recognized and explained.

Statistical Significance Is Not the Same as Clinical Importance

A study may report a statistically significant result that has little practical importance.

Conversely, a small study may identify a potentially important difference but lack sufficient precision to establish whether the effect is real or clinically meaningful.

Healthcare professionals should therefore look beyond the reported p-value.

Effect size, absolute differences, confidence intervals and baseline risk often provide more useful information.

Consider a hypothetical example.

Suppose a clinical event occurs in 10 out of every 100 people in a comparison group and eight out of every 100 people receiving an intervention.

The relative risk reduction is 20%, which may sound substantial.

The absolute difference, however, is two fewer events per 100 people over the stated follow-up period.

Both figures describe the same hypothetical result, but they communicate different aspects of its importance.

Whether the intervention is worthwhile also depends on how serious the event is, how certain the estimate is and what burdens or harms accompany treatment.

An intervention that prevents a serious event may be valuable even when the absolute benefit is modest.

By contrast, a small improvement in a laboratory measurement may have limited practical value if achieving it requires substantial cost, time or treatment burden.

Confidence intervals are equally important.

They show the range of effect estimates compatible with the data under the statistical model and assumptions used.

A wide confidence interval may indicate considerable uncertainty about the size of the benefit or harm.

A narrow interval suggests greater statistical precision, although precision alone does not establish that the study is free from bias.

For Lifestyle Medicine research, clinical interpretation should therefore consider the size, precision and relevance of the effect rather than simply whether a result crossed a conventional threshold for statistical significance.

Surrogate Outcomes and Patient-Important Outcomes Are Not Interchangeable

Lifestyle interventions often influence intermediate clinical measurements.

Weight, blood pressure, glycated hemoglobin, lipid concentrations, physical fitness and inflammatory biomarkers can provide valuable information.

They may be appropriate outcomes for particular clinical and research questions.

However, improvement in an intermediate measurement does not always establish improvement in outcomes that matter directly to patients.

A reduction in blood pressure is supported by extensive evidence linking blood-pressure control with cardiovascular outcomes. Nevertheless, the implications of a specific intervention still depend on the relevant evidence, population and treatment context.

For less established biomarkers, the relationship with long-term clinical benefit may be much more uncertain.

A study showing a change in an inflammatory marker should not automatically be described as demonstrating prevention of cardiovascular disease or cancer.

Similarly, improvement in an exercise-performance measure does not necessarily establish better long-term functioning or survival.

Healthcare professionals should distinguish between what was measured and what is being claimed.

An intervention can have a legitimate role in improving symptoms, function or quality of life even when evidence for effects on mortality is limited.

There is no need to exaggerate its benefits to justify its appropriate use.

From Individual Studies to the Certainty of the Evidence

Clinical recommendations should rarely depend on one attractive study.

A more reliable approach is to evaluate the total body of relevant evidence.

Systematic reviews and meta-analyses can help by identifying, evaluating and synthesizing multiple studies.

However, a systematic review is not automatically high-quality evidence.

Its conclusions depend on the studies included, the search and selection methods, risk-of-bias assessment, synthesis methods and the interpretation of differences between studies.

The GRADE approach provides a structured method for assessing certainty in evidence for specific outcomes.

For intervention effects, randomized trials generally begin at a higher initial certainty level than nonrandomized evidence, but that assessment may change after methodological evaluation.

The central domains considered when certainty may need to be reduced are risk of bias, inconsistency, indirectness, imprecision and publication bias.

Risk of bias concerns problems in the design, conduct or analysis of studies.

Inconsistency arises when findings differ across studies in ways that cannot be adequately explained.

Indirectness concerns differences between the evidence and the question being considered.

Imprecision reflects uncertainty about the estimated effect, including whether the available data are sufficient to support a clinically meaningful conclusion.

Publication bias concerns the possibility that the available published evidence does not adequately represent all relevant research, particularly when studies with favorable or statistically significant results are more likely to be reported.

In appropriate circumstances, other considerations may increase confidence in nonrandomized evidence, such as a sufficiently large effect, a credible dose-response relationship or residual confounding that would be expected to reduce rather than explain the observed effect.

These judgments require methodological expertise and should not be applied mechanically.

GRADE describes certainty using four categories: high, moderate, low and very low.

Importantly, certainty is assessed for the body of evidence relevant to a particular outcome, not simply assigned to an article because of its design or journal.

The same intervention may have more certain evidence for one outcome than another.

For example, evidence that a program improves physical function may be more certain than evidence that it reduces long-term mortality.

This distinction is essential when translating research into clinical recommendations.

Evidence Certainty and Recommendation Strength Are Different

A strong recommendation does not always require high-certainty evidence for every outcome, and high-certainty evidence does not automatically lead to a strong recommendation.

Guideline development involves more than estimating effectiveness.

The GRADE Evidence-to-Decision framework, updated through ongoing methodological work in 2026, emphasizes the balance of benefits and harms, patient values, resource requirements, equity, acceptability and feasibility.

These considerations are particularly important in Lifestyle Medicine.

A program may produce measurable health benefits but require substantial professional time, expensive equipment or repeated consultations.

Another intervention may have smaller average benefits but be inexpensive, acceptable and feasible across a wider population.

The appropriate decision depends on the clinical context and the intended users.

Recommendations should also consider whether patients have different preferences or face different burdens.

For one person, an intensive behavioral program may be realistic and desirable. For another, work schedules, caregiving responsibilities or transportation costs may make the same intervention difficult to sustain.

Evidence informs the decision, but it does not remove the need for professional judgment and shared decision-making.

Practical Tools for Critical Appraisal

Healthcare professionals do not need to become research methodologists to read scientific literature more critically.

Several internationally recognized tools can support the appraisal process.

Cochrane's Risk of Bias 2 (RoB 2) is designed for evaluating the risk of bias in specific results from randomized trials.

It examines the randomization process, deviations from intended interventions, missing outcome data, outcome measurement and selective reporting of results.

The assessment focuses on the trustworthiness of a particular result rather than assigning a simple quality label to an entire article.

Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) supports structured assessment of nonrandomized studies examining intervention effects.

It addresses issues including confounding, participant selection, classification of interventions, deviations from intended interventions, missing data, outcome measurement and selection of reported results.

A key feature is the use of a hypothetical target trial to clarify what causal comparison the observational study is attempting to estimate.

ROBINS-I is a specialized methodological tool. It should not be applied indiscriminately to every type of observational research, such as descriptive prevalence surveys or ordinary prognostic studies.

AMSTAR 2, a critical appraisal tool for systematic reviews, evaluates methodological features of reviews that include randomized or nonrandomized intervention studies.

It examines matters such as whether a review was planned in advance, whether its literature search was sufficiently comprehensive, whether risk of bias was assessed appropriately and whether the synthesis and conclusions adequately reflect the limitations of included studies.

AMSTAR 2 has 16 items and places particular importance on critical methodological domains.

Its developers caution against simply adding the items into one numerical score because a high total can conceal serious weaknesses in a critical area.

The Cochrane Handbook for Systematic Reviews of Interventions provides more detailed guidance for those conducting or critically interpreting evidence syntheses.

The GRADE Book offers structured guidance on evaluating certainty and moving from evidence to recommendations.

The University of Oxford's Centre for Evidence-Based Medicine also provides practical critical appraisal resources that can be useful for everyday professional learning.

These tools serve different purposes.

RoB 2 assesses risk of bias in randomized trial results. ROBINS-I focuses on nonrandomized studies of intervention effects. AMSTAR 2 assesses the conduct of systematic reviews. GRADE considers certainty across a body of evidence and supports decisions about recommendations.

Using a tool that does not match the research design can produce misleading conclusions.

For routine professional reading, a brief structured appraisal may be sufficient. More complex reviews, guideline development and high-stakes clinical decisions may require formal assessment by appropriately trained reviewers.

A Practical Example: Interpreting a Lifestyle Intervention Study

Consider a hypothetical randomized study evaluating a digital lifestyle-coaching program among office workers.

Participants receive smartphone-based counseling, step-count monitoring and weekly feedback for 12 weeks. The study reports an increase in daily steps and a modest reduction in body weight compared with usual care.

The findings may be encouraging, but several questions remain.

Were participants randomly allocated using appropriate methods? Did both groups receive comparable attention apart from the intervention being tested? How many participants completed follow-up? Were the results based on all randomized participants or only those who remained engaged with the application?

Were step counts measured objectively and consistently? Were the reported outcomes specified before the study began?

The intervention itself also requires examination.

Did participants receive regular professional support? Were they highly motivated volunteers? Did they have reliable internet access, flexible working hours and sufficient health literacy to use the digital system?

If these conditions were important to the program's success, they may affect how the findings apply elsewhere.

The outcome also matters.

An increase in daily steps over 12 weeks does not establish that the intervention prevents cardiovascular events or produces sustained health benefits over several years.

The appropriate conclusion would be that the program improved the outcomes actually measured in the study population, subject to the study's methodological limitations.

For a healthcare organization in Viet Nam, the next question is whether a similar program could be delivered to the intended patients.

A digital intervention tested among employed urban adults may need modification for older people, patients with low digital literacy or communities with limited internet access.

The program may also require different levels of staff support, follow-up and technical resources.

This example shows how critical appraisal connects scientific findings with implementation decisions.

The purpose is not to reject useful research because it was conducted elsewhere.

It is to understand what the evidence supports and what would be required to apply it responsibly.

A Practical Test of Applicability to Viet Nam

Evidence generated outside Viet Nam can be highly relevant to Vietnamese healthcare.

International clinical trials and systematic reviews provide important information about biological mechanisms, intervention effectiveness and clinical outcomes.

However, their applicability should be considered rather than assumed.

Population differences are one consideration.

Age, disease severity, comorbidities, baseline risk, nutritional status and other clinical characteristics may influence intervention outcomes.

For example, a program tested among relatively healthy adults may not directly apply to older patients with frailty or several chronic diseases.

Cultural and behavioral context also matters.

Dietary interventions need to consider Vietnamese foods, family eating patterns, restaurant meals, affordability and available ingredients.

Physical activity interventions may need to account for occupational demands, traffic, urban design, air pollution, heat and access to safe spaces.

Sleep interventions may need to reflect shift work, long working hours and family circumstances.

Healthcare delivery conditions can affect whether an intervention is feasible.

A program requiring weekly consultations with a multidisciplinary team may work well in a research center but be difficult to reproduce in a smaller clinic.

Healthcare organizations should consider the availability of qualified professionals, referral services, monitoring systems, consultation time and financial resources.

Patient preferences and social circumstances influence acceptability.

An intervention that requires substantial time, travel or out-of-pocket expenditure may be difficult for patients with limited income or caregiving responsibilities.

A program may therefore need adaptation even when its scientific rationale is sound.

Finally, local professional and regulatory requirements determine how an intervention can be delivered within Vietnamese healthcare.

Scientific evidence does not independently authorize a practitioner or healthcare facility to provide regulated clinical services.

Applicability should therefore include both clinical suitability and the ability to deliver the intervention legally, safely and sustainably.

These considerations should not be used to dismiss international evidence simply because it comes from another country.

They help distinguish the effectiveness of an intervention under research conditions from its likely performance in Vietnamese practice.

When Local Evidence Is Needed

Not every international finding needs to be repeated through a new randomized trial in Viet Nam.

For interventions with a strong international evidence base, local research may be more valuable when it examines feasibility, acceptability, implementation costs, access, adherence and sustainability.

For example, international evidence may support a particular lifestyle intervention for improving blood-pressure control.

A Vietnamese implementation study might examine whether the intervention can be incorporated into existing primary care services, what training is required, whether patients attend follow-up and whether the program remains affordable.

Such research answers a different but important question.

The original clinical evidence addresses whether the intervention can work. Local implementation research helps determine whether it can be delivered effectively in a particular setting.

In some cases, local effectiveness trials may still be necessary, especially when the intervention has been substantially modified, the target population differs markedly from the original studies or important uncertainty remains.

The decision should be based on the existing evidence and the question that still needs answering.

For Lifestyle Medicine in Viet Nam, implementation science may be particularly valuable because many important barriers concern delivery rather than basic biological plausibility.

Potential Harms and Treatment Burden Must Be Considered

Lifestyle interventions are sometimes assumed to be harmless because they involve daily behaviors rather than drugs or procedures.

This assumption is unsafe.

A restrictive dietary intervention may increase nutritional risk in a person with advanced chronic kidney disease or cancer-related weight loss.

Substantial dietary change may alter glucose control and medication requirements in someone taking insulin or other glucose-lowering medicines.

Exercise may require modification for people with significant cardiovascular, neurological or musculoskeletal conditions.

For people experiencing post-exertional symptom exacerbation associated with Long COVID, fixed increases in exercise may worsen symptoms rather than improve function.

These examples illustrate why the assessment of benefit must be accompanied by an assessment of potential harm.

Treatment burden also matters.

A program requiring extensive monitoring, multiple appointments or significant lifestyle disruption may be difficult to sustain.

There may also be opportunity costs when time and resources are directed toward interventions with uncertain value instead of care with established benefit.

For high-risk patients, an inappropriate lifestyle program may delay necessary diagnostic evaluation or medical treatment.

Evidence-based Lifestyle Medicine should therefore consider clinical safety, feasibility, cost and the patient's overall treatment burden.

The fact that an intervention is described as natural or nonpharmacological does not remove the need for appropriate evidence.

Evidence Appraisal and Professional Scope in Viet Nam

An intervention may be supported by scientific evidence without being appropriate for every healthcare professional to deliver.

Under Viet Nam's Law on Medical Examination and Treatment, as reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, regulated clinical activities are subject to professional licensing, authorized scopes and healthcare facility requirements.

Decree No. 96/2023/NĐ-CP and Circular No. 32/2023/TT-BYT, as amended, provide further implementing requirements.

Circular No. 25/2026/TT-BYT amended selected provisions of Circular No. 32/2023/TT-BYT and other Ministry of Health regulations. Its general effective date was August 15, 2026, while Articles 2 and 3 took effect on July 1, 2026.

These instruments do not establish an independent clinical scope of practice simply because an activity is described as Lifestyle Medicine.

For healthcare professionals, this means that the final decision to adopt an intervention must consider legal and professional responsibilities alongside clinical evidence.

A nutrition intervention requiring specialized clinical assessment, a therapeutic exercise program involving significant medical risk or a decision to modify prescribed medication may require particular professional qualifications and authorization.

General scientific education should not be confused with independent clinical treatment.

International certification and educational programs also do not automatically expand Vietnamese professional practice authority.

This is an important distinction between knowing that an intervention may be effective and being legally qualified to deliver it.

Conflicts of Interest and Selective Reporting

Financial interests and other conflicts can influence research, but they should be examined carefully rather than used as shortcuts for judging study quality.

Industry funding does not automatically invalidate a study, just as independent funding does not guarantee reliable methods.

The important questions concern transparency, study design, the role of the funder, prespecified outcomes, statistical analysis and whether unfavorable or inconclusive findings were adequately reported.

Selective reporting is especially relevant when researchers measure many outcomes or conduct multiple analyses.

A study may examine several dietary, metabolic and psychological outcomes but emphasize only those showing statistically significant changes.

Without access to a prespecified protocol or statistical analysis plan, it may be difficult to determine whether the reported findings were selected after the results became known.

Publication bias creates another concern.

Studies reporting favorable findings may be more likely to appear in the published literature than studies with neutral or unfavorable results.

This can distort the overall impression of effectiveness, particularly when systematic reviews rely only on available published studies.

For Lifestyle Medicine, careful appraisal is important because interventions and products are sometimes promoted commercially using selected scientific findings.

A credible professional assessment should consider the complete body of evidence rather than the most attractive results.

Turning Evidence Into Clear Professional Communication

Critical appraisal is useful only if its conclusions can be communicated accurately.

A healthcare professional reading a study should be able to explain what was investigated, what the study found and how much confidence should be placed in the result.

The explanation should distinguish findings from interpretation.

For example, a study demonstrating improved physical activity after a counseling intervention supports a claim about physical activity under the studied conditions.

It does not automatically support a claim that the intervention prevents heart attacks.

A study associating a dietary pattern with lower mortality may provide important evidence, but its observational design and remaining uncertainty should be acknowledged when making causal claims.

Likewise, an intervention shown to be effective among selected participants should not automatically be described as suitable for every patient.

Words such as proven, reverses, cures, prevents or eliminates the need for medication should be used carefully.

They imply outcomes that may be more definitive than the available evidence supports.

A useful professional summary can be written in a few sentences.

It should identify the study population and intervention or exposure, describe the relevant comparison, report the principal outcome and effect, acknowledge important limitations, and explain what the findings may mean for the intended setting.

Where evidence is uncertain, that uncertainty should be stated.

This approach makes scientific communication more useful without requiring every educational article to become a technical research report.

A Practical Evidence Appraisal Note for Healthcare Professionals

When reviewing an individual study for professional use, it can be helpful to prepare a short written appraisal before making a recommendation.

The note should begin with the clinical or public health question being addressed. It should then identify the study design, target population, intervention or exposure, comparator and outcomes.

The next part should examine methodological concerns.

For a randomized trial, these may include randomization, missing data, deviations from the intervention and outcome measurement.

For observational research, they may include confounding, participant selection, reverse causation and measurement bias.

The appraisal should then summarize the main results, including the magnitude and precision of the estimated effect.

It should explain whether the outcomes are directly meaningful to patients or represent intermediate measurements.

The next judgment concerns the overall evidence.

Is the study consistent with other relevant research? Is there a systematic review or current clinical guideline? How certain is the evidence for the outcome being considered?

Finally, the note should consider practical application.

Does the study population resemble the intended patients? Is the intervention feasible in Viet Nam? Are there important clinical risks, costs or equity concerns? Can the intervention be delivered within the relevant professional and regulatory framework?

The conclusion should identify what the evidence supports, what remains uncertain and whether further assessment or local adaptation is required.

This is not a replacement for a formal systematic review or guideline-development process.

It is a practical discipline that can help professionals avoid translating a single published result into an overly broad recommendation.

A Central Evidence Reference for Lifestyle Medicine in Viet Nam

As Lifestyle Medicine develops in Viet Nam, its credibility will depend partly on how carefully scientific evidence is interpreted.

Different clinical areas will raise different questions.

Nutrition research may involve dietary patterns, food processing and long-term observational evidence.

Physical activity research may include randomized trials, functional assessments and population studies.

Behavior-change research may focus on intervention fidelity, adherence, patient preferences and the effectiveness of different delivery models.

Implementation research may examine whether a program can be integrated into existing healthcare services and sustained over time.

These areas require different methods, but they share the need for transparent critical appraisal.

For the Vietnam Lifestyle Medicine Alliance, strengthening evidence appraisal can support professional education, scientific knowledge translation and more responsible public communication.

A central methodological reference can also help establish consistent expectations across other VLMA educational articles.

When discussing a particular intervention, future resources can distinguish what was studied, what outcomes were measured, how certain the evidence is, what limitations remain and how the findings relate to Vietnamese healthcare.

This is particularly important when emerging research produces findings that attract public attention before their clinical implications are fully understood.

The objective is not to make every healthcare professional a systematic review specialist.

It is to strengthen the ability to recognize trustworthy evidence, identify overstatements and make better-informed decisions.

Evidence-Based Practice Requires Both Rigor and Judgment

Lifestyle Medicine brings together interventions supported by different types and levels of evidence.

Some are backed by large randomized trials and well-established clinical recommendations. Others rely on observational research, smaller trials, expert consensus or emerging evidence.

The appropriate response is neither to treat all findings as equally certain nor to dismiss useful evidence simply because it does not come from a randomized trial.

The scientific task is to identify the question, evaluate the methods, examine the results and judge the totality of relevant evidence.

The clinical task is to determine whether that evidence applies to a particular person, whether the potential benefits outweigh the harms and whether the intervention can be delivered appropriately.

For healthcare professionals in Viet Nam, these tasks also involve local culture, healthcare resources, patient preferences, professional responsibilities and legal requirements.

A study can be scientifically credible without providing a complete answer for Vietnamese practice. A clinical intervention can be beneficial in one population while requiring substantial modification in another.

Recognizing these differences does not weaken evidence-based medicine. It makes its application more responsible.

The central question should therefore move beyond “Is there a published study supporting this intervention?”

A more useful question is:

“How trustworthy is the evidence, what exactly does it show, and is it sufficient to support this decision for this person or population in Viet Nam?”

That is the foundation of responsible evidence-based Lifestyle Medicine.

References and Further Reading
  1. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. First published online October 28, 2025. doi:10.1177/15598276251379821.

  2. Rea BL, Cheema S, Lanza S, et al. Governance and Update Process for Lifestyle Medicine Core Competencies and Definitions. American Journal of Lifestyle Medicine. 2026;20(7):1116–1123. doi:10.1177/15598276261424740.

  3. GRADE Working Group. GRADE Book: Overview of the GRADE Approach; Indirectness; Introduction to the Evidence-to-Decision Frameworks. Methodological guidance updated in 2026.

  4. Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024.

  5. Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing Risk of Bias in a Randomized Trial. In: Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024.

  6. Sterne JAC, Hernán MA, McAleenan A, Reeves BC, Higgins JPT. Chapter 25: Assessing Risk of Bias in a Non-randomized Study. In: Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024.

  7. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-randomised Studies of Healthcare Interventions, or Both. BMJ. 2017;358. doi:10.1136/bmj.j4008.

  8. Katz DL, Karlsen MC, Chung M, et al. Hierarchies of Evidence Applied to Lifestyle Medicine: Introduction of a Strength-of-Evidence Approach Based on a Methodological Systematic Review. BMC Medical Research Methodology. 2019;19:178. doi:10.1186/s12874-019-0811-z.

  9. Johansson M, Niklasson A, Albarqouni L, et al. Guidelines Recommending That Clinicians Advise Patients on Lifestyle Changes: A Popular but Questionable Approach to Improve Public Health. Annals of Internal Medicine. 2024;177:1425–1427. doi:10.7326/ANNALS-24-00283.

  10. Rosenfeld RM. Guidelines Recommending That Clinicians Advise Patients on Lifestyle Changes. Annals of Internal Medicine. 2025;178:1213. doi:10.7326/ANNALS-25-01850.

  11. Centre for Evidence-Based Medicine, University of Oxford. Critical Appraisal Tools. Professional methodological resources.

  12. Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH, Law on Medical Examination and Treatment. February 26, 2026.

  13. Government of Viet Nam. Decree No. 96/2023/NĐ-CP Detailing Selected Provisions of the Law on Medical Examination and Treatment. December 30, 2023.

  14. Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT Detailing Selected Provisions of the Law on Medical Examination and Treatment. December 31, 2023, as subsequently amended.

  15. Ministry of Health of Viet Nam. Circular No. 25/2026/TT-BYT Amending Selected Ministry of Health Regulations. June 30, 2026. General effective date: August 15, 2026; Articles 2 and 3 effective July 1, 2026.

Educational and Professional Scope Note

This article is intended for professional education, scientific knowledge exchange and general information. It does not constitute an official clinical practice guideline, a formal systematic review, an individualized medical recommendation or an authoritative interpretation of Vietnamese law.

The examples used to illustrate research appraisal and evidence interpretation are hypothetical unless a specific published study is identified. They are intended to demonstrate methodological principles rather than establish the effectiveness or safety of particular clinical interventions.

International evidence-appraisal frameworks and clinical research findings do not independently authorize clinical activities or establish professional scopes of practice in Viet Nam. Clinical interventions must remain consistent with applicable Vietnamese regulations, professional qualifications, authorized practice scopes, healthcare facility requirements and relevant clinical guidance.

The Vietnam Lifestyle Medicine Alliance is a physician-led professional platform focused on evidence-based Lifestyle Medicine, professional education, scientific knowledge exchange and responsible implementation. It does not independently issue clinical practice guidelines with regulatory authority or provide individualized medical treatment.

Scientific evidence and methodological guidance continue to evolve. Professional recommendations should be reviewed as new research, clinical guidelines and applicable Vietnamese regulations become available.

Vietnam Lifestyle Medicine Alliance

Evidence-Based Lifestyle Medicine for Viet Nam.

Contact

contact@vlma.org

Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC

+84 909 228 476

+84 84 9999 911

© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.

A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.

VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.

VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.

VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.